Skip to main content

Table 1 Baseline characteristics of patients with severe HFMD caused by EV71 in the non-CVVHDF group and the CVVHDF group

From: Continuous hemodiafiltration as a rescue therapy for patients with cardiopulmonary failure caused by enterovirus-71: a retrospective observational study in a PICU

Characteristics Non-CVVHDF group
(n = 12)
CVVHDF group
(n = 17)
P
Age, month 21.0 (8.3, 23.8) 23.0 (12.5, 24.0) 0.372
Male, n 8 10 0.717
Severity    0.979
 Stage 3, n 7 10  
 Stage 4, n 5 7  
Body weight, kg 10.6 (8.3, 14.4) 11.0 (10.0, 14.4) 0.565
Body temperature, °C 39.7 (39.4, 39.8) 39.7 (39.3, 40.0) 0.518
Heart rate, bpm 188 (171, 195) 187 (178, 198) 0.982
LVEF, % 38 (26, 44) 37 (24, 47) 0.773
CI, L/min/m2 2.89 (2.23,3.63) 2.73 (1.92, 3.95) 0.642
Systolic blood pressure, mmHg 132.0 (76.0, 150.5) 139 (102, 155) 0.116
Acute kidney injury, n 2 4 0.653
Fluid overload, n 3 6 0.694
Mechanical ventilator, n 12 17 /
Vasoactive agents
 Milrinone, n 7 7 0.462
 Phentolamine, n 1 0 0.414
 Sodium nitroprusside, n 4 2 0.198
 Dopamine, n 4 6 0.913
 Dobutamine, n 9 13 1.000
 Norepinephrine, n 1 3 0.622
 Adrenaline, n 2 4 1.000
  1. LVEF Left ventricular ejection fraction, CI Cardiac index. Continuous variables were summarized as the median (IQR)